Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Fabrizio, V. A., Boelens, J. J., Mauguen, A., Baggott, C., Prabhu, S., Egeler, E., Mavroukakis, S., Pacenta, H., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., … Curran, K. J. (2022). Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Advances, 6(7), 1961–1968. https://doi.org/10.1182/bloodadvances.2021006418
Authors:
Vanessa A. Fabrizio
Michael R. Verneris
Amy K. Keating
Jaap Jan Boelens
Kevin J. Curran
Audrey Mauguen
Christina Baggott
Michael Kunicki
Liora M. Schultz
Snehit Prabhu
Emily Egeler
Sharon Mavroukakis
Holly Pacenta
Theodore W. Laetsch
Christine L. Phillips
Christa Krupski
Jenna Rossoff
Heather E. Stefanski
Vasant Chinnabhandar
Julie-An Talano
Amy Moskop
Steven P. Margossian
Gary Douglas Myers
Rachel Wilcox
Nicole A. Karras
Patrick A. Brown
Cara A. Rabik
Muna Qayed
Michelle Hermiston
A. Yasemin Goksenin
Prakash Satwani
Crystal L. Mackall
Affiliated Authors:
Prakash Satwani
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2021006418
PMID:
34788386
DOI:
10.1182/bloodadvances.2021006418
Journal:
Blood Advances
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: